Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study

被引:37
作者
Yan, Shumei [1 ,2 ,3 ]
He, Fan [4 ]
Gao, Bei [5 ]
Wu, Huini [6 ]
Li, Mei [1 ,2 ,3 ]
Huang, Liyun [1 ,2 ,3 ]
Liang, Jianzhong [1 ,2 ,3 ]
Wu, Qiuliang [1 ,2 ,3 ]
Li, Yong [1 ,2 ,3 ]
机构
[1] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[5] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[6] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 06期
关键词
APOBEC3B; non-small-cell lung cancer; immunohistochemistry; prognosis; BREAST-CANCER; CYTIDINE DEAMINASES; DECREASED SURVIVAL; EXPRESSION; POLYMORPHISM; ACTIVATION; EVOLUTION; CARCINOMA; MUTATION; DELETION;
D O I
10.7150/jca.14030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer ranks as the most common and lethal malignancy in America and worldwide. APOBEC3B is a newly identified DNA cytosine deaminase, which is supposed to function as a major source of DNA mutation in many different tumors. In this study, we combine the data of online databases and two hundred and twenty-one primary non-small-cell lung carcinoma (NSCLC) specimens from Sun Yat-sen University Cancer Center to investigate, for the first time, the clinical role of APOBEC3B in lung cancer. We found that the APOBEC3 expression was commonly elevated in NSCLC tissues and overexpression of APOBEC3B was correlated with unfavorable prognosis of the patients with NSCLC. Furthermore, APOBEC3B expression was associated with nodal status, TNM staging and adjuvant chemotherapy of the patients with NSCLC. Further research is warranted.
引用
收藏
页码:618 / 625
页数:8
相关论文
共 50 条
  • [21] Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
    Tokunaga, Eriko
    Yamashita, Nami
    Tanaka, Kimihiro
    Inoue, Yuka
    Akiyoshi, Sayuri
    Saeki, Hiroshi
    Oki, Eiji
    Kitao, Hiroyuki
    Maehara, Yoshihiko
    PLOS ONE, 2016, 11 (12):
  • [22] Progressive APOBEC3B mRNA expression in distant breast cancer metastases
    Sieuwerts, Anieta M.
    Schrijver, Willemijne A. M. E.
    Dalm, Simone U.
    de Weerd, Vanja
    Moelans, Cathy B.
    ter Hoeve, Natalie
    van Diest, Paul J.
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    PLOS ONE, 2017, 12 (01):
  • [23] Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif
    Land, Allison M.
    Wang, Jiayi
    Law, Emily K.
    Aberle, Ryan
    Kirmaier, Andrea
    Krupp, Annabel
    Johnson, Welkin E.
    Harris, Reuben S.
    ONCOTARGET, 2015, 6 (37) : 39969 - 39979
  • [24] APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines
    Onguru, Onder
    Yalcin, Serap
    Rosemblit, Cinthia
    Zhang, Paul J.
    Kilic, Selim
    Gunduz, Ufuk
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 87 - 92
  • [25] Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population
    Goehler, Stella
    Da Silva Filho, Miguel Inacio
    Johansson, Robert
    Enquist-Olsson, Kerstin
    Henriksson, Roger
    Hemminki, Kari
    Lenner, Per
    Foersti, Asta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 273 - 276
  • [26] Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population
    Stella Göhler
    Miguel Inacio Da Silva Filho
    Robert Johansson
    Kerstin Enquist-Olsson
    Roger Henriksson
    Kari Hemminki
    Per Lenner
    Asta Försti
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 273 - 276
  • [27] The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population
    Gliniewicz, Katarzyna
    Kluzniak, Wojciech
    Wokolorczyk, Dominika
    Huzarski, Tomasz
    Stempa, Klaudia
    Rudnicka, Helena
    Jakubowska, Anna
    Szwiec, Marek
    Jarkiewicz-Tretyn, Joanna
    Naczk, Mariusz
    Kluz, Tomasz
    Debniak, Tadeusz
    Gronwald, Jacek
    Lubinski, Jan
    Narod, Steven A. A.
    Akbari, Mohammad R. R.
    Cybulski, Cezary
    GENES, 2023, 14 (07)
  • [28] MEK1/2 regulates APOBEC3B and polymerase iota-induced mutagenesis in head and neck cancer cells
    Schulz, Dominik
    Piontek, Guido
    Zissler, Ulrich M.
    Multhoff, Gabriele
    Wirth, Markus
    Pickhard, Anja
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5581 - 5590
  • [29] Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort
    Vitiello, Glauco Akelinghton Freire
    Pereira, Nathalia de Sousa
    Amarante, Marla Karine
    Banin-Hirata, Bruna Karina
    Campos, Clodoaldo Zago
    de Oliveira, Karen Brajao
    Losi-Guembarovski, Roberta
    Watanabe, Maria Angelica Ehara
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (06) : 1523 - 1532
  • [30] High APOBEC3B mRNA Expression Is Associated with Human Papillomavirus Type 18 Infection in Cervical Cancer
    de Oliveira, Gisele R.
    Carvalho, Pedro S.
    Vieira, Valdimara C.
    Curty, Gislaine
    Basto, Diogo L.
    Moreira, Miguel Angelo M.
    Soares, Marcelo A.
    VIRUSES-BASEL, 2022, 14 (12):